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Specificity and Actions of an Arylaspartate Inhibitor of
Glutamate Transport at the Schaffer Collateral-CA1
Pyramidal Cell Synapse
Weinan Sun., Katie M. Hoffman., David C. Holley, Michael P. Kavanaugh*
Center for Structural and Functional Neuroscience, The University of Montana, Missoula, Montana, United States of America
Abstract
In this study we characterized the pharmacological selectivity and physiological actions of a new arylaspartate glutamate
transporter blocker, L-threo-ß-benzylaspartate (L-TBA). At concentrations up to 100 mM, L-TBA did not act as an AMPA
receptor (AMPAR) or NMDA receptor (NMDAR) agonist or antagonist when applied to outside-out patches from mouse
hippocampal CA1 pyramidal neurons. L-TBA had no effect on the amplitude of field excitatory postsynaptic potentials
(fEPSPs) recorded at the Schaffer collateral-CA1 pyramidal cell synapse. Excitatory postsynaptic currents (EPSCs) in CA1
pyramidal neurons were unaffected by L-TBA in the presence of physiological extracellular Mg2+ concentrations, but in
Mg2+-free solution, EPSCs were significantly prolonged as a consequence of increased NMDAR activity. Although L-TBA
exhibited approximately four-fold selectivity for neuronal EAAT3 over glial EAAT1/EAAT2 transporter subtypes expressed in
Xenopus oocytes, the L-TBA concentration-dependence of the EPSC charge transfer increase in the absence of Mg2+ was the
same in hippocampal slices from EAAT3 +/+ and EAAT3 2/2 mice, suggesting that TBA effects were primarily due to block
of glial transporters. Consistent with this, L-TBA blocked synaptically evoked transporter currents in CA1 astrocytes with a
potency in accord with its block of heterologously expressed glial transporters. Extracellular recording in the presence of
physiological Mg2+ revealed that L-TBA prolonged fEPSPs in a frequency-dependent manner by selectively increasing the
NMDAR-mediated component of the fEPSP during short bursts of activity. The data indicate that glial glutamate
transporters play a dominant role in limiting extrasynaptic transmitter diffusion and binding to NMDARs. Furthermore,
NMDAR signaling is primarily limited by voltage-dependent Mg2+ block during low-frequency activity, while the relative
contribution of transport increases during short bursts of higher frequency signaling.
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Introduction
Five major subtypes of excitatory amino acid transporters exist
in the CNS, and three of these (EAAT1-3; also known as GLAST,
GLT-1, and EAAC1) are expressed in forebrain with distinct
distribution patterns on astrocytes (EAAT1 and EAAT2) and
neurons (EAAT3) [1]. Studies utilizing glutamate uptake inhibitors
broadly indicate that the transporters play important roles in
glutamate homeostasis, and that they can in some cases shape
receptor dynamics during synaptic transmission [2]. While the
synaptic effects of glutamate transport inhibition vary w
idely in different brain regions, studies of the
hippocampal Schaffer collateral-CA1 pyrami-
dal cell (SC-PC) synapse generally indicate that
transporter activity does not strongly modify
synaptic AMPAR responses [3,4; but see 5,6].
In contrast, extrasynaptic NMDAR activity is
enhanced by glutamate uptake block in this
region [7–11].
The relative contributions of the glial EAAT1 and EAAT2 and
neuronal EAAT3 subtypes to restricting the spread of synaptically
released glutamate from the SC-PC synapse is presently unclear.
EAAT2 and EAAT3 are the dominant transporters in forebrain
astrocytes and neurons, respectively, while EAAT1 is found on
forebrain astrocytes at lower levels [12]. The widely used
glutamate uptake blocker DL-TBOA blocks EAAT2 and
EAAT3-mediated [3H]L-Glu uptake with IC50 values approxi-
mately seven-fold lower than for EAAT1 [13], and studies utilizing
DL-TBOA indicate that it can induce spillover of synaptic
glutamate onto NMDARs in hippocampus [7–11]. Selective
inhibition of the postsynaptic neuronal transporter EAAT3 by
intracellular ion substitution during whole cell recording or genetic
manipulation also leads to augmentation of NMDAR-mediated
EPSCs as well as changes in synaptic plasticity [9,11]. Nevertheless
there is still uncertainty surrounding the relative contributions and
detailed roles of neuronal and glial EAAT subtypes in hippocam-
pus. Another issue concerns the general role of glutamate transport
in restricting NMDAR signaling in the hippocampus under
physiological conditions, since this effect has only been reported
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in conditions permissive for channel activity, i.e. voltage clamp of
the postsynaptic neuron at positive potentials or in Mg2+-free
ACSF [7–11].
Threo-ß-benzylaspartate (TBA) is a new arylaspartate derivative
that is structurally related to TBOA, but with a shorter aryl linkage
lacking an ether group. In contrast to DL-TBOA, L-TBA displays
moderate selectivity for the neuronal EAAT3 subtype over both
EAAT1 and EAAT2 [14]. In this work we show that L-TBA does
not cross-react with ionotropic glutamate receptors expressed on
CA1 pyramidal cells at concentrations used to block uptake. We
examined the effects of L-TBA on excitatory synaptic transmission
at the Schaffer-CA1 synapse in wild-type and transgenic mice
lacking the neuronal EAAT3 glutamate transporter in order to
gain insights into the respective roles of glial and neuronal
transporters. We also compared L-TBA actions on postsynaptic
signaling with and without voltage clamp using whole-cell or
extracellular recording in order to gain insights into the role of
transporters in more physiologically relevant conditions. The data
suggest that glial transporters restrict synaptically released
transmitter binding to NMDARs to a significantly greater extent
than neuronal transporters. Further, voltage-dependent Mg2+
block plays a dominant role in limiting NMDAR signaling during
low-frequency activity, while the relative influence of transport
increases during short bursts of activity.
Methods
Ethics statement
Mice and frogs used in this study were treated in a manner to
minimize suffering, and were anesthetized with isofluorane or
Tricaine respectively, and decapitated in accordance with NIH
and University of Montana regulations. The study was approved
by the University’s IACUC (protocol approval 03905).
Drugs
Drugs and chemicals were purchased from Sigma, except
CNQX and DL-APV (Tocris) and DL-TBOA (Ascent). Stock
solutions of TBOA and TBA were dissolved in DMSO at 50 mM.
Data are presented as mean 6 S.E. and statistical significance
evaluated by Student’s paired (drug effects) or unpaired (transgenic
effect) t-test.
Oocyte recording
Stage V Xenopus oocytes were microinjected with approxi-
mately 50 ng of human EAAT1, EAAT2, or EAAT3 cRNA and
two-microelectrode voltage clamp recordings were made 3–5 days
later at 22u with Molecular Devices amplifiers and A/D interfaces
[14]. Oocytes were superfused with Ringer containing (in mM) 96
NaCl, 4 KCl, 1.8 CaCl2, 1.0 MgCl2, 5 HEPES pH 7.4 and were
voltage clamped at 230 mV.
Computational modeling
Human EAAT3 sequence (GenBank http://www.ncbi.nlm.nih.
gov) was aligned with the Protein Data Bank (PDB) sequence of
the archaeal homologue GltPh [15,16]. The EAAT3 homology
model was constructed by threading the aligned sequence along
PDB coordinates using the SwissProt server (http://swissmodel.
expasy.org//SWISS-MODEL.html). The resulting model was
optimized through local energy minimizations of regions with
high steric and electrostatic interference using the AMBER7 force
field in the Tripos SYBYL8.0 platform. Representations of L-TBA
and L-TBOA were docked using GOLD v.3.0.1 (http://www.
ccdc.cam.ac.uk/) into the EAAT3 model and evaluated using the
ChemScore scoring function. Structures were seeded within a
sphere of radius 8Å from the a-carbon of L-3-Br-TBOA in
2NWW. The structures from three separate docking run (30
seeds/run) were evaluated for electrostatic interactions with
residues that have been shown to confer substrate and inhibitor
specificity [15–18]. We screened docked structures for two
interactions between EAAT3 R447 and inhibitor distal oxygens
and between EAAT3 D444 and the inhibitor a-amino group.
Structures with the lowest estimated DG values were incorporated
into the homology model and represented using PyMol1.3.
Mouse hippocampal slice preparation and recording
P18-26 CD1 wild-type or EAAT3 (2/2) siblings (Raymond
Swanson, UCSF) were anesthetized with isofluorane and decap-
itated in accordance with University of Montana IACUC
regulations (protocol approval number 039 05). The brain was
rapidly dissected and placed in ice-cold solution containing (in
mM): 80 NaCl, 24 NaHCO3, 25 glucose, 75 sucrose, 2.5 KCl,
1.25 NaH2PO4, 0.5 CaCl2, 5 MgCl2, 1 ascorbic acid, 3 Na
pyruvate. The solution was saturated with 95% O2 and 5% CO2
(pH 7.3). 300 mm thick coronal hippocampal slices were cut using
a vibratome (VT1200S Leica, Germany), then hemisected and
placed in artificial cerebral spinal fluid (ACSF) containing (in mM):
126 NaCl, 2.5 KCl, 1.2 MgCl2, 2.4 CaCl2, 1.2 NaH2PO4, 11.4
glucose, and 21.4 NaHCO3 saturated with 95%O2 and 5% CO2
(pH 7.3) and maintained at 30uC. Slices were allowed at least
1 hour to recover before being placed in a submersion-type
recording chamber perfused at 1.6–2.0 ml/minute with ACSF at
30uC. Slices were visualized on an upright fixed-stage microscope
(Olympus BX51WI) equipped with infrared-differential interfer-
ence contrast optics. The recording pipettes (3–6MV resistance)
were filled with internal solution containing (in mM): 110 Cs
methanesulfonate, 38 CsCl, 10 HEPES, 10 Na-phosphocreatine,
0.1 EGTA, 4.0 Mg-ATP, 0.3 GTP, 5 QX-314, pH = 7.3. Series
resistance (typically 15–20 MOhm), was monitored and recording
terminated if a change .20% was observed. Holding potential
was 260 to 270 mV. 100 mM picrotoxin was added to the ACSF
for whole-cell recordings and an incision was made between CA3
and CA1.
Extracellular field excitatory post synaptic potentials (fEPSPs)
were recorded using glass electrodes filled with ACSF. Recordings
were made with analog-digital converters and amplifiers from
Molecular Devices, and data were acquired at 20 kHz and filtered
at 5–10 kHz. Acquisition and analysis software was Axograph
(version 1.1.6). EPSCs and fEPSPs were induced with 100 ms
current pulses between 0.1 mA– 0.4 mA administered through
ACSF-filled stimulating pipettes placed in stratum radiatum.
EPSC charge transfer changes and fEPSP prolongation were
quantified by integrating the area from the peak of the response
(normalized to control) to 100 ms after the peak. Voltage-time
integrals of the fEPSPs elicited by a burst of 2 or 3 stimuli were
calculated after subtraction of responses to 1 and 2 stimuli,
respectively. Whole cell recordings of synaptically activated
transport currents (STCs) in CA1 astrocytes in stratum radiatum
were made with assistance of fluorescence visualization of
astrocytes following 20 min. incubation in 2 mM SR-101 (Sigma)
and 1 h washout. STC recordings were made in ACSF including
(in mM) 100 picrotoxin, 50 DL-APV, 20 CNQX, 10 8-CPT.
Astrocytes were clamped at 290 mV (resting potential -
8061.5 mV; 9.16.8 MOhm input resistance, n = 4). Peak current
amplitudes were determined following baseline subtraction of
persistent current at 200 ms following stimulation. The identity of
the STC in astrocytes that was blocked by L-TBA was further
confirmed by DL-TBOA [19] sensitivity.
L-TBA Effects on Glutamate Transport and Signaling
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Outside-out patches were pulled from the soma of CA1
pyramidal neurons from CD1 mice (P9-22) identified under
transmitted IR DIC optics. Patches were held at 260 mV with a
pipette solution containing (in mM): 150 K-gluconate, 10 HEPES,
8 NaCl, 0.5 EGTA, 4 MgATP, and 0.3 NaGTP, pH 7.3. Patch
recordings were made at room temperature. Drug solution was
applied through a 200 mm diameter theta tube attached to a
piezoelectric bimorph. Solution change kinetics were estimated
following patch rupture by measuring junction currents during
switches between iso- and hypo-osmotic solutions as shown above
current records. NMDAR currents were recorded in nucleated
patches with Mg2+-free ACSF containing 20 mM CNQX and
20 mM glycine. L-glutamate with or without L-TBA (each at
100 mM) were applied in alternating order for 100 ms or 400 ms
to induce AMPAR or NMDAR currents respectively. Averages of
5–10 responses to repetitive application are shown with an
interpulse interval of 3 sec for AMPAR experiments and 10 sec for
NMDAR experiments.
Results
Computational docking of L-TBA with glutamate
transporters
We constructed an EAAT3 model using published homologous
archaeal GltPh structures [15,16] and docked aryl-aspartate
analogs in order to identify and compare plausible structural
interactions. A single Na+ ion was positioned in the structure
according to the structural determination of a Tl+ ion in the GltPh/
L-3-Br-TBOA complex [15] and further corresponding to
electrostatic predictions of Na+ ion binding sites in EAAT3 [20].
The EAAT3 residues R447 and D444 interact with the c-
carboxylate and the a-amino group of transported glutamate
respectively, and these residues determine substrate specificity
[17,18]. The computationally docked L-TBA complex suggested
corresponding electrostatic interactions between the blocker
carboxyl and amino groups with the R447 and D444 residues in
EAAT3 (Figure 1A). The most energetically favorable L-TBA
complexes corresponded to the benzyl group orientation of L-3-
Br-TBOA that was determined in the GltPh crystal structure, with
interactions between the ring and non-polar residues near the tip
of HP2. Interestingly, when computational docking of L-TBOA
was performed, an energetically favorable conformation was
observed that involved an interaction of R447 with the ether
group of the blocker. This alternate orientation positions the
benzyl group in an ‘up’ conformation perpendicular to the
membrane and parallel to TMD7, and aligns it with non-polar
residues in TM7, TM8 and HP2 (Figure 1B). Docking energies
(Table 1) predict that L-3-Br-TBOA could orient in either
conformation while L-TBOA is predicted to predominantly align
in the perpendicular, ‘up’ orientation, and L-TBA aligns
predominantly in the ‘down’ conformation parallel to the
membrane plane.
Interaction of L-TBA with neuronal and glial glutamate
transporters
L-TBA inhibits uptake mediated by heterologously expressed
EAATs with preference for the neuronal glutamate transporter
subtype EAAT3 [14]. However, transport currents mediated by
the major glial subtypes are also blocked in Xenopus oocytes
expressing the transporters (Figure 2A,B). To examine the actions
of L-TBA on glial transporters in situ, synaptically activated
transport currents (STCs) were recorded in astrocytes in stratum
radiatum of area CA1 in mouse hippocampal slices. Responses
evoked by Shaffer collateral stimulation in the presence of the
ionotropic receptor blockers CNQX (20 mM) and DL-APV
(50 mM) revealed a current with properties consistent with glial
transporters EAAT1 and EAAT2, together with a slowly decaying
potassium current as previously described [21]. The STC, or
transporter-mediated component of the evoked current, peaked
and decayed within approximately 20 ms. The peak STC was
blocked 67610% by 30 mM L-TBA (n = 4; Figure 2C).
Effects of TBA on fast excitatory synaptic transmission
Prior to characterizing the effects of L-TBA on excitatory
synaptic transmission, its potential direct actions on ionotropic
glutamate receptors were examined using a fast piezo solution
switch to apply L- Glu and/or L-TBA to outside-out patches from
CA1 pyramidal neurons. Fast application of 100 mM L-Glu
induced robust AMPAR and NMDAR currents, while application
of 100 mM L-TBA alone failed to induce measurable currents
(Figure 3). Co-application of 100 mM L-TBA showed no
antagonism of the AMPAR (101.262.0% of control; n = 4;
p.0.6) or NMDAR currents (98.762.3% of control; n = 5,
p = 0.59; Fig. 3C) induced by 100 mM L-Glu.
The amplitude of fEPSPs elicited by .05 Hz stimulation in
stratum radiatum was not affected by application of 30 mM L-
TBA (10063% of control; n = 41 slices). There was also no
significant change in paired-pulse facilitation (50 ms pulse interval)
of the peak amplitude of fEPSPs by application of L-TBA (control,
1.726.03; L-TBA, 1.606.08; p..05). In whole cell voltage clamp
Figure 1. Interaction of L-TBA with EAATs. (A) Docking of L-TBA (green) and L-TBOA (gray) in EAAT3 model showing overlap of functional
groups interacting with R447 and D444, with benzyl groups oriented toward extracellular loop HP2 as described in [14]. (B) Surface depiction of the
transporter binding site (hydrophobic regions blue) showing L-TBA and alternate docking orientation of L-TBOA with benzyl ring aligned in alternate
hydrophobic pocket.
doi:10.1371/journal.pone.0023765.g001
L-TBA Effects on Glutamate Transport and Signaling
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recordings from CA1 pyramidal neurons, the effect of L-TBA on
EPSC kinetics was highly [Mg2+]-dependent (Figure 4). In Mg2+-
free ACSF, 30 mM L-TBA significantly prolonged evoked EPSCs.
The charge transfer in the presence of L-TBA was 14166% of
that without drug (n = 6; p,.05), with no significant effect on the
peak amplitude (10267% of control, n = 6). The prolonging effect
of L-TBA on EPSC kinetics was presumed to be mediated by
NMDAR activity, because in the presence of physiological
(1.2 mM) Mg2+, 30 mM TBA had no effect on the time course
of the EPSC (charge transfer 10163%; p = .78, n = 4; Fig.4A1).
The prolongation was also not seen in the presence of 50 mM DL-
APV in the absence of Mg2+ (data not shown). The effects of L-
TBA on the EPSC charge transfer were concentration-dependent
and not statistically different for slices from EAAT3 (+/+) and
EAAT3 (-/-) mice (Figure 4C,D).
Extracellular recording in the presence of physiological
(1.2 mM) Mg2+ revealed an effect of L-TBA on fEPSP kinetics
that exhibited pronounced frequency-dependence. 30 mM L-TBA
slightly prolonged fEPSPs elicited by low-frequency (.05 Hz)
stimulation, while time-integrals of fEPSPs recorded during a
brief 20 Hz burst prolonged the time course of the fEPSP
significantly further (Figure 5; 3167% vs 69621% for the first and
second fEPSPs, respectively, n = 9, p = .02). Increasing stimulus
strength to increase the fEPSP magnitude by an amount
comparable to the frequency facilitation had no effect on the
time course of the fEPSP (data not shown). The L-TBA-induced
prolongation at both low and high frequencies was not observed in
the presence of 50 mM APV, indicating that an increase in
NMDAR signaling caused the fEPSP prolongation (Figure 5).
Discussion
Selective glutamate uptake blockers are critical tools for
studying the roles of glutamate transporters in modulating synaptic
Figure 2. Effects of L-TBA on native and recombinant transporters. (A) Representative recording from voltage-clamped Xenopus oocyte
expressing astrocyte transporter subtype EAAT2. 100 mM L-TBA partially blocks equimolar L-Glu uptake current mediated by EAAT2. (B) Summary of
L-TBA concentration-dependence of block of 100 mM L-Glu currents in oocytes expressing EAAT1-3, showing approximately four-fold selectivity for
EAAT3 by least-squares minimized fits to mean data generating IC50 values of 56, 52, and 13 mM, respectively. (C) Effect of 30 mM L-TBA on
synaptically activated transport current (STC) in hippocampal CA1 astrocyte. Currents in the presence or absence of L-TBA were evoked by
stimulation in stratum radiatum in the continuous presence of ionotropic receptor antagonists (see methods). 30 mM L-TBA blocked 66.7610.4 of the
peak STC (n = 4).
doi:10.1371/journal.pone.0023765.g002
Table 1. Computational docking results.
Structure ChemScore DG (kJ mol21) orientation
L-TBOA 18.07 222.14 perpendicular
L-TBOA 15.01 218.62 parallel
L-TBA 2 2 perpendicular*
L-TBA 19.70 23.62 parallel
L-3-Br-TBOA 20.19 23.09 perpendicular
L-3-Br-TBOA 18.04 23.90 parallel
*structure not found by energy minimization algorithm.
doi:10.1371/journal.pone.0023765.t001
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activity [6–11]. Both the widely used DL-TBOA (19) and the
newer analog characterized in this study, L-TBA, are ß-substituted
aryl aspartate analogs. The data demonstrate that L-TBA is
selective for glutamate transporters over ionotropic glutamate
receptors expressed on pyramidal neurons, as it neither antago-
nized ionotropic receptor responses to equimolar glutamate nor
activated responses at concentrations up to 100 mM. Unlike
TBOA, TBA lacks an ether linkage between the aryl group and
the amino acid, resulting in a slight change in distance and bond
angle of the benzyl ring relative to the aspartyl group (Figure 2A).
The computationally predicted docking orientation of L-TBA was
similar to the reported structure of L-3-Br-TBOA complexed with
the archaeal homolog GltPh [15], with key electrostatic interac-
tions involving R447 and D444 in TMD7 of EAAT3. Predicted
interactions of the benzyl group with hydrophobic regions of
EAAT3 were also in agreement with the structure of L-3-Br-
TBOA complexed with GltPh. In this conformation, the blocker
prevents closure of the extracellular-facing HP2 loop which
normally occludes bound L-aspartate (16). Interestingly, a distinct
orientation was predicted for L-TBOA because of the alternate
interaction of R447 with the ether oxygen of L-TBOA. This
interaction preserves the a-amino group interaction with D444 but
causes the benzyl group to rotate to an orientation perpendicular
to the membrane plane, fitting into a hydrophobic domain
bordered by TMDs 7/8 and HP2 (Figure 2B). These predicted
conformations suggest that the HP2 loop position in the L-TBA
and L-TBOA transporter complexes may slightly differ. In terms
of transporter selectivity, L-TBOA exhibits moderate selectivity for
the glial EAAT2 and neuronal EAAT3 subtypes, while L-TBA
exhibits moderate selectivity for EAAT3 [13,14]. While L-TBA
and DL-TBOA differ in subtype selectivity, each exhibits
significant subtype cross-reactivity at concentrations typically used.
Because the effects of L-TBA on EPSC and fEPSP kinetics
observed in this study were not significantly different in wild-type
and transgenic mice lacking the EAAT3 gene, we conclude that
they were primarily caused by inhibition of glial transporters
EAAT1 and/or EAAT2, which would be predicted to be
approximately 75% occupied at the inhibitor concentration used
(30 mM) based on the KD values of 12 mM and 9 mM for EAAT1
and EAAT2, respectively. This is roughly consistent with the
67610% observed block of the peak synaptic transporter currents
in astrocytes 30 mM L-TBA. While inhibition of glial transport
appears to have predominantly mediated the effects on NMDARs
Figure 3. Representative recordings from outside-out patches excised from CA1 pyramidal neurons illustrating AMPAR and
NMDAR responses to rapid application of 100 mM L-glutamate and/or 100 mM L-TBA for durations indicated by solution exchange
traces above. Responses at 260 mV showing lack of agonist or antagonist actions of L-TBA on AMPARs (A; with 1.2 mM Mg2+) and NMDARs (B; with
0 mM Mg2+/20 mM glycine/20 mM CNQX). Scale bars are 50/200 ms and 50/100 pA for AMPAR/NMDAR responses respectively. (C) Summary of mean
effects of 100 mM L-TBA on 100 mM L-Glu AMPAR and NMDAR responses.
doi:10.1371/journal.pone.0023765.g003
Figure 4. Actions of L-TBA (30 mM) on postsynaptic responses
at the CA1 Schaffer collateral-pyramidal neuron synapse of
EAAT3 +/+ (A) and EAAT3 2/2 (B) mice. Representative whole cell
recordings (260 mV) showing effect of L-TBA on EPSCs evoked by
stimulation in stratum radiatum in the presence (A1, B1) and absence
(A2, B2) of physiological extracellular Mg
2+ (1.2 mM). (C) Summary of
data showing EPSC charge transfer increase in slices from EAAT3 (+/+)
and (2/2) mice by 30 mM L-TBA in the absence and presence of Mg2+
(n = 5–7 slices; p,0.05). Data normalized to the charge transfer in slices
from EAAT3 (+/+) mice. (D) Summary data showing no significant
difference in L-TBA concentration-dependence of EPSC charge transfer
increase (normalized to control) for EAAT3 +/+ (open squares) and
EAAT3 2/2 (filled squares) (n = 4).
doi:10.1371/journal.pone.0023765.g004
L-TBA Effects on Glutamate Transport and Signaling
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we observed, it is important to note that selective block of neuronal
transport has been reported to result in changes in both synaptic
transmission and plasticity that were not addressed here [9,11].
The mean increase in EPSC charge transfer caused by removal of
extracellular Mg2+ was slightly larger in slices from EAAT3 (2/2)
compared to wild-type mice, but this effect did not reach statistical
significance (Figure 4C). The L-TBA concentration-dependance of
the effects on NMDAR responses was also not statistically different
in slices from EAAT3 (+/+) and EAAT3 (2/2) mice (Figure 4D).
The threshold for the L-TBA response in both genotypes was #
3 mM, suggesting that a relatively small fractional block of glial
transporters (# 25%) affects excitatory postsynaptic responses to a
greater extent than essentially complete block of neuronal
transport.
Past work suggesting that transporters control extrasynaptic
glutamate spillover has relied on examining the effects of
transporter block in conditions where NMDAR activity is tonically
enabled (i.e. under voltage clamp at depolarized potentials or with
Mg2+-free solution). Consistent with work from several groups [6–
11], we found that EAAT inhibition significantly prolonged
EPSCs recorded at the Schaffer-CA1 pyramidal cell synapse in
Mg2+-free conditions due to enhanced NMDAR signaling. L-TBA
had no effect on postsynaptic responses in voltage clamp
conditions with NMDARs blocked by physiological [Mg2+].
Because voltage-dependent Mg2+ block of NMDARs is dynamic
during synaptic transmission, gaining greater insight into the role
of glutamate transport in modulating synaptic activity will require
the use of selective transport blockers in physiological conditions
without voltage clamp. In this study, we have begun to address this
issue and have shown that NMDAR-mediated components of
fEPSPs can be isolated that are dependent on glutamate
transporter activity in a frequency-dependent manner. The small
effect of L-TBA on the kinetics of fEPSPs elicited by low-frequency
stimulation in physiological Mg2+ was increased during brief bursts
of higher frequency synaptic activity, and this prolongation was
blocked by the NMDAR antagonist APV. This effect was not
likely to be due simply to frequency-facilitation of transmitter
release, because increasing stimulus strength did not affect the
kinetics of fEPSPs elicited by low frequency stimulation. This
suggests that the influence of glial glutamate transporters on
NMDAR signaling may vary with synaptic frequency through
postsynaptic voltage responses. A deeper quantitative understand-
ing of the role of glutamate transporters in excitatory synaptic
transmission will require further studies accounting for these
variables.
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